Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

“It’s so hard taking pills when you don’t know what they’re for”: a qualitative study of patients’ medicine taking behaviours and conceptualisation of medicines in the context of rheumatoid arthritis

Authors: Boitshoko Kobue, Shirra Moch, Jennifer Watermeyer

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

Patients with chronic illnesses are often required to take lifelong medication to alleviate symptoms and prevent disease progression. Many patients find it difficult to adhere to prescribed medication for various reasons, some of which may link to the way they conceptualise medicines and understand their illness and treatment. This study explores the medicine taking behaviours of patients presenting with Rheumatoid Arthritis (RA), a chronic inflammatory autoimmune disease. We focused particularly on patients’ conceptualisation and understanding of medicines within this disease context, against a backdrop of scarce healthcare resources.

Methods

We conducted semi-structured interviews with 18 female patients at a rheumatology clinic in South Africa, as well as a review of participants’ medical records. We conducted a secondary analysis of the data using thematic analysis and framework analysis principles.

Results

Participants reported a range of medicine taking behaviours including self-medicating, adding complementary and alternative medicines (CAM) or traditional remedies, and sometimes acquiring prescribed medicines illegally. Participants provided insights into their understanding of what constitutes a medicine and what substances can be added to a prescribed regimen, which impacted on adherence. Importantly, the majority of participants demonstrated poor understanding of their illness, medications, regimens and dosage instructions.

Conclusions

Medicine taking in the context of RA, within the studied demographic, is complex and appears strongly mediated by individual and contextual factors. Poor patient understanding, individual conceptualisation of medicines and medicine taking, and the availability of a range of additional medicines and remedies impact on adherence. Based on these findings, we make some suggestions for how healthcare providers can play a greater role in educating patients living with RA about medicines, CAM and traditional remedies, as well as medicine taking behaviours.
Literature
1.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J, ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.PubMedPubMedCentralCrossRef
2.
Felzmann H. Adherence, compliance, and concordance; an ethical perspective. Nurse Prescribing. 2012;10(8):406–11.CrossRef
3.
4.
Martin L. Barriers and keys to treatment adherence and health behaviour change. In: Martin L, DiMatteo MR, editors. The Oxford handbook of health communication, behavior change, and treatment adherence. New York: Oxford University Press; 2013. p. 9–22.CrossRef
5.
Toh CT, Jackson B, Gascard DJ, Manning AR, Tuck EJ. Barriers to medication adherence in chronic heart failure patients during home visits. J Pharm Pract Res. 2010;40(1):27–30.CrossRef
6.
Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22(6):805–10.PubMedPubMedCentralCrossRef
7.
8.
Lehane E, McCarthy G. Medication non-adherence--exploring the conceptual mire. Int J Nurs Pract. 2009;15(1):25–31.PubMedCrossRef
9.
Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.PubMedCrossRef
10.
Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity–concerns framework. J Psychosom Res. 2008;64(1):41–6.PubMedCrossRef
11.
Barry CA, Stevenson FA, Britten N, Barber N, Bradley CP. Giving voice to the lifeworld. More humane, more effective medical care? A qualitative study of doctor-patient communication in general practice. Soc Sci Med. 2001;53(4):487–505.PubMedCrossRef
12.
Penn C, Watermeyer J, Evans M. Why don’t patients take their drugs? The role of communication, context and culture in patient adherence and the work of the pharmacist in HIV/AIDS. Patient Educ Couns. 2011;83(3):310–8.PubMedCrossRef
13.
Germond P, Cochrane JR. Healthworlds: conceptualizing landscapes of health and healing. Sociology. 2010;44(2):307–24.CrossRef
14.
Dohnhammar U, Reeve J, Walley T. Patients’ expectations of medicines – a review and qualitative synthesis. Health Expect. 2015. doi:10.​1111/​hex.​12345.
15.
16.
Homer D, Nightingale P, Jobanputra P. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A randomized controlled trial comparing adherence and satisfaction. Musculoskeletal Care. 2009;7(2):78–92.PubMedCrossRef
17.
Watermeyer J, Penn C. “Tell me so I know you understand”: pharmacists’ verification of patients’ comprehension of antiretroviral dosage instructions in a cross-cultural context. Patient Educ Couns. 2009;75:205–13.PubMedCrossRef
18.
Denford S, Frost J, Dieppe P, Cooper C, Britten N. Individualisation of drug treatments for patients with long-term conditions: a review of concepts. BMJ Open. 2014;4(3):e004172.PubMedPubMedCentralCrossRef
19.
Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34.PubMedCrossRef
20.
Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509.PubMedCrossRef
21.
Gómez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, BIOBADASER Group. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicentre active-surveillance report. Arthritis Rheum. 2003;48(8):2122–7.PubMedCrossRef
22.
Elliott RA. Poor adherence to medication in adults with rheumatoid arthritis: reasons and solutions. Dis Manag Health Out. 2008;16(1):13–29.CrossRef
23.
Kaur A, Nain P, Nain J. Herbal plants used in the treatment of rheumatoid arthritis: a review. Int J Pharm Pharm Sci. 2012;4 Suppl 4:44–57.
24.
25.
Hodkinson B, Musenge E, Ally M, Meyer PWA, Anderson R, Tikly M. Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol. 2012;31(4):613–9.PubMedCrossRef
26.
Kumar K, Gorgon C, Barry R, Shaw K, Horne R, Raza K. “It’s like taking poison to kill poison but I have to get better”: a qualitative study of the beliefs about medicines in rheumatoid arthritis and systemic lupus erythematosus in patients of South Asian origin. Lupus. 2011;20(8):837–44.PubMedCrossRef
27.
Picchianti-Diamanti A, Germano V, Ferlito C, Migliore A, D’Amelio R, Lagana B. Health related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept. Qual Life Res. 2010;19(6):821–6.PubMedCrossRef
28.
Mody GM, Cardiel MH. Challenges in the management of rheumatoid arthritis in developing countries. Best Pract Res Clin Rheumatol. 2008;22(4):621–41.PubMedCrossRef
29.
Coovadia H, Jewkes R, Barron P, Sanders D, McIntyre D. The health and health system of South Africa: historical roots of current public health challenges. Lancet. 2009;374(9692):817–34.PubMedCrossRef
30.
Deumert A. ‘It would be nice if they could give us more language’ – Serving South Africa’s multilingual patient base. Soc Sci Med. 2010;71(1):53–61.PubMedCrossRef
31.
Peltzer K. Utilization and practice of Traditional/Complementary/Alternative medicine (TM/CAM) in South Africa. Afr J Tradit Complement Altern Med. 2009;6(2):175–85.PubMedPubMedCentral
32.
Moshabela M, Pronyk P, Williams N, Schneider H, Lurie M. Patterns and implications of medical pluralism among HIV/AIDS patients in rural South Africa. AIDS Behav. 2011;15(4):842–52.PubMedPubMedCentralCrossRef
33.
Kobue BO. Factors affecting medication adherence in rheumatoid arthritis. Unpublished Masters dissertation. University of the Witwatersrand, Johannesburg, South Africa. 2013. Available from the Wits Institutional Repository environment on DSpace (WIReDSpace). http://​146.​141.​12.​21/​handle/​10539/​14581. Accessed Apr 2017.
34.
35.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
36.
37.
Spencer L, Ritchie J, Ormston R, O’Connor W, Barnard M. Analysis: principles and processes. In: Ritchie J, Lewis J, McNaughton Nicholls C, Ormston R, editors. Qualitative research practice: a guide for social science students and researchers. 2nd ed. London: Sage; 2014.
38.
Eickhoff C, Hammertein A, Griese N, Schulz M. Nature and frequency of drug-related problems in self-medication (over the counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21(3):254–60.PubMedCrossRef
39.
Brooker C. Pocket Medical Dictionary, 15th ed. London: Churchill Livingstone; 2003.
40.
Tong A, Howell M, Wong G, Webster A, Howard K, Craig JC. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrol Dial Transplant. 2011;26(1):344–54.PubMedCrossRef
41.
Bennin F, Rother HA. “But it’s just paracetamol”: caregivers’ ability to administer over-the-counter painkillers to children with the information provided. Patient Educ Couns. 2015;98(3):331–7.PubMedCrossRef
42.
43.
44.
Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB. Medication adherence behaviour and priorities among older adults with CKD: a semi-structured interview study. Am J Kidney Dis. 2010;56(3):439–46.PubMedPubMedCentralCrossRef
45.
Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res. 1992;16(2):143–63.CrossRef
46.
Wagner EH, Bennett SM, Austin BT, Greene SM, Schaefer JK, Vonkorff M. Finding common ground: patient-centeredness and evidence based chronic illness care. J Altern Complement Med. 2005;11 Suppl 1:S7–15.PubMed
47.
48.
Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol. 2007;64(5):710–11.PubMedPubMedCentralCrossRef
49.
Dowell J, Williams B, Snadden D. Patient-centered prescribing: seeking concordance in practice. Oxford: Radcliffe Publishing; 2007. p. 16–8.
50.
Lempp H, Scott DL, Kingsley GH. Patients’ views on the quality of health care for rheumatoid arthritis. Rheumatology (Oxford). 2006;45(12):1522–8.CrossRef
51.
Crawford P, Brown B. Fast healthcare: brief communication, traps and opportunities. Patient Educ Couns. 2011;82(1):3–10.PubMedCrossRef
52.
Koenig CJ, Ho EY, Trupin L, Dohan D. An exploratory typology of provider responses that encourage and discourage conversation about complementary and integrative medicine during routine oncology visits. Patient Educ Couns. 2015;98(7):857–63.PubMedPubMedCentralCrossRef
Metadata
Title
“It’s so hard taking pills when you don’t know what they’re for”: a qualitative study of patients’ medicine taking behaviours and conceptualisation of medicines in the context of rheumatoid arthritis
Authors
Boitshoko Kobue
Shirra Moch
Jennifer Watermeyer
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2246-8

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue

Research article

Improving Hospital at Home for frail older people: insights from a quality improvement project to achieve change across regional health and social care sectors

Research article

Comparing chronic condition rates using ICD-9 and ICD-10 in VA patients FY2014–2016

Research article

Evaluation of the use of health care services for non-communicable disease and prevention by children and adolescents in south Italy

Research article

Is the co-location of GPs in primary care centres associated with a higher patient satisfaction? Evidence from a population survey in Italy

Research article

Health system preparedness for integration of mental health services in rural Liberia

Research article

The role of simulation in mixed-methods research: a framework & application to patient safety